Qingfei Jiang

1.5k total citations
29 papers, 1.1k citations indexed

About

Qingfei Jiang is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Qingfei Jiang has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 6 papers in Hematology and 5 papers in Genetics. Recurrent topics in Qingfei Jiang's work include RNA regulation and disease (17 papers), RNA Research and Splicing (14 papers) and DNA Repair Mechanisms (5 papers). Qingfei Jiang is often cited by papers focused on RNA regulation and disease (17 papers), RNA Research and Splicing (14 papers) and DNA Repair Mechanisms (5 papers). Qingfei Jiang collaborates with scholars based in United States, Canada and Sweden. Qingfei Jiang's co-authors include Catriona Jamieson, Leslie Crews, Myron F. Goodman, Roger Woodgate, Michael M. Cox, M Zipeto, Mark D. Minden, Frida Holm, Angela C. Court and Sheldon Morris and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Qingfei Jiang

28 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingfei Jiang United States 13 943 236 152 103 79 29 1.1k
Amy C. Fan United States 10 572 0.6× 77 0.3× 82 0.5× 44 0.4× 76 1.0× 19 785
Zhong Yu United States 12 687 0.7× 88 0.4× 116 0.8× 45 0.4× 44 0.6× 15 859
Victoria V. Hargreaves United States 7 420 0.4× 48 0.2× 118 0.8× 62 0.6× 56 0.7× 9 571
Andrew Whale United Kingdom 11 599 0.6× 127 0.5× 87 0.6× 19 0.2× 55 0.7× 16 881
Jerome R. Lo Ten Foe Netherlands 8 617 0.7× 185 0.8× 196 1.3× 74 0.7× 31 0.4× 15 762
Nadine Hein Australia 14 849 0.9× 115 0.5× 42 0.3× 42 0.4× 59 0.7× 36 1.1k
Yaara Oren Israel 7 419 0.4× 147 0.6× 81 0.5× 40 0.4× 79 1.0× 10 584
Christopher Sundberg United States 7 495 0.5× 107 0.5× 60 0.4× 30 0.3× 55 0.7× 7 680
Masahiro Nobuhara Japan 14 218 0.2× 83 0.4× 110 0.7× 55 0.5× 76 1.0× 25 597
Xianbo Huang China 15 328 0.3× 106 0.4× 95 0.6× 79 0.8× 101 1.3× 42 606

Countries citing papers authored by Qingfei Jiang

Since Specialization
Citations

This map shows the geographic impact of Qingfei Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingfei Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingfei Jiang more than expected).

Fields of papers citing papers by Qingfei Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingfei Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingfei Jiang. The network helps show where Qingfei Jiang may publish in the future.

Co-authorship network of co-authors of Qingfei Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Qingfei Jiang. A scholar is included among the top collaborators of Qingfei Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingfei Jiang. Qingfei Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mark, Adam, Jessica Pham, Karina Vera, et al.. (2024). RNA editing regulates host immune response and T cell homeostasis in SARS-CoV-2 infection. PLoS ONE. 19(8). e0307450–e0307450. 3 indexed citations
2.
Zhang, Haoran, Jessica Pham, Larisa Balaian, et al.. (2024). Malignant A-to-I RNA editing by ADAR1 drives T cell acute lymphoblastic leukemia relapse via attenuating dsRNA sensing. Cell Reports. 43(2). 113704–113704. 15 indexed citations
3.
Sinha, Indranil, Konstantinos A. Papadakis, Anna Nilsson, et al.. (2024). The CNS microenvironment promotes leukemia cell survival by disrupting tumor suppression and cell cycle regulation in pediatric T-cell acute lymphoblastic leukemia. Experimental Cell Research. 437(2). 114015–114015. 1 indexed citations
4.
Jiang, Qingfei, et al.. (2024). Protocol for in vitro co-culture assay for rapid expansion of human T cell acute lymphoblastic leukemia. STAR Protocols. 5(2). 103103–103103. 1 indexed citations
5.
Pham, Jessica, Haoran Zhang, Roman Šášik, et al.. (2023). Malignant a-to-I RNA Editing By ADAR1 Drives T-Cell Acute Lymphoblastic Leukemia Relapse Via Attenuating dsRNA Sensing. Blood. 142(Supplement 1). 4147–4147. 1 indexed citations
6.
Crews, Leslie, Wenxue Ma, Luisa Ladel, et al.. (2023). Reversal of malignant ADAR1 splice isoform switching with Rebecsinib. Cell stem cell. 30(3). 250–263.e6. 40 indexed citations
7.
Jiang, Qingfei, M Zipeto, Jessica Pham, et al.. (2019). Hyper-Editing of Cell-Cycle Regulatory and Tumor Suppressor RNA Promotes Malignant Progenitor Propagation. Cancer Cell. 35(1). 81–94.e7. 71 indexed citations
8.
Ma, Wenxue, Ping Chen, Qingfei Jiang, et al.. (2017). Telomerase Inhibition Impairs Self-Renewal of ß-Catenin Activated Myeloproliferative Neoplasm Progenitors. Blood. 130. 2860. 1 indexed citations
9.
Lazzari, Elisa, Nathaniel P. Delos Santos, Amber Miller, et al.. (2017). Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma. Nature Communications. 8(1). 1922–1922. 87 indexed citations
10.
Jiang, Qingfei, Leslie Crews, Frida Holm, & Catriona Jamieson. (2017). RNA editing-dependent epitranscriptome diversity in cancer stem cells. Nature reviews. Cancer. 17(6). 381–392. 86 indexed citations
11.
Zipeto, M, Angela C. Court, Anil Sadarangani, et al.. (2016). ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis. Cell stem cell. 19(2). 177–191. 183 indexed citations
12.
Ma, Wenxue, Ping Chen, Nathaniel P. Delos Santos, et al.. (2016). Telomerase Inhibition with Imetelstat Eradicates β-Catenin Activated Blast Crisis Chronic Myeloid Leukemia Stem Cells. Blood. 128(22). 3065–3065. 3 indexed citations
13.
Jiang, Qingfei, et al.. (2016). RNA Editing Enzyme ADAR1 Accelerates Normal Hematopoiesis Cell Cycle By Regulating microRNA Biogenesis. Blood. 128(22). 887–887. 1 indexed citations
14.
Zipeto, M, et al.. (2015). RNA rewriting, recoding, and rewiring in human disease. Trends in Molecular Medicine. 21(9). 549–559. 51 indexed citations
15.
Crews, Leslie, Qingfei Jiang, M Zipeto, et al.. (2015). An RNA editing fingerprint of cancer stem cell reprogramming. Journal of Translational Medicine. 13(1). 52–52. 45 indexed citations
16.
Ma, Wenxue, Alejandro Gutiérrez, Daniel Goff, et al.. (2012). NOTCH1 Signaling Promotes Human T-Cell Acute Lymphoblastic Leukemia Initiating Cell Regeneration in Supportive Niches. PLoS ONE. 7(6). e39725–e39725. 29 indexed citations
17.
Goff, Daniel, Alice Shih, Angela C. Court, et al.. (2010). The Pan-Bcl-2 Family Inhibitor 97C1 Targets Blast Crisis Chronic Myeloid Leukemia Stem Cells but Spares Normal Cord Blood Progenitor Cells. Blood. 116(21). 516–516. 1 indexed citations
18.
Jiang, Qingfei, et al.. (2010). A new model for SOS-induced mutagenesis: how RecA protein activates DNA polymerase V. Critical Reviews in Biochemistry and Molecular Biology. 45(3). 171–184. 100 indexed citations
19.
Jiang, Qingfei, Kiyonobu Karata, Roger Woodgate, Michael M. Cox, & Myron F. Goodman. (2009). The active form of DNA polymerase V is UmuD′2C–RecA–ATP. Nature. 460(7253). 359–363. 114 indexed citations
20.
Schlacher, Katharina, Qingfei Jiang, Roger Woodgate, & Myron F. Goodman. (2006). Purification and Characterization of Escherichia coli DNA Polymerase V. Methods in enzymology on CD-ROM/Methods in enzymology. 408. 378–390. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026